India’s pharma deal street is abuzz with action around in-licensing and co-marketing/co-promotion. Front-line Indian firms are leveraging their commercial strength to firm up alliances with foreign companies seeking to push deeper and make a larger impact for their new products in the country's competitive market.
Typically, such alliances also allow Indian firms to expand their portfolios or plug gaps therein, with the foreign companies keen...







